Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 67 results.
User Information
Export Records
  1. 1.   Structural mimicry drives HIV-1 Rev-mediated HERV-K expression
  2. O'Carroll, Ina P; Fan,Lixin; Kroupa,Tomas; McShane, Erin K; Theodore, Christophe; Yates, Elizabeth A; Kondrup, Benjamin; Ding,Jienyu; Martin, Tyler S; Rein,Alan; Wang,Yun-Xing
  3. Journal of molecular biology. 2020, Dec 4; 432(24): pii: S0022-2836(20)30630-6.
  1. 2.   An evaluation of the RNase H inhibitory effects of Vietnamese medicinal plant extracts and natural compounds
  2. Tai, B. H.; Nhut, N. D.; Nhiem, N. X.; Quang, T. H.; Nguyen, T. T. N.; Bui, T. T. L.; Huong, T. T.; Wilson, J.; Beutler, J. A.; Ban, N. K.; Cuong, N. M.; Kim, Y. H.
  3. Pharmaceutical Biology. 2011, Oct; 49(10): 1046-1051.
  1. 3.   Nanoinformatics: an emerging area of information technology at the intersection of bioinformatics, computational chemistry and nanobiotechnology
  2. Gonzalez-Nilo, F. G.-N. F.; Perez-Acle, T.; Guinez-Molinos, S.; Geraldo, D. A.; Sandoval, C.; Yevenes, A.; Santos, L. S.; Laurie, V. F.; Mendoza, H.; Cachau, R. E.
  3. Biological Research. 2011 44(1): 43-51.
  1. 4.   Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer
  2. Vercruysse, T.; Pawar, S.; De Borggraeve, W.; Pardon, E.; Pavlakis, G. N.; Pannecouque, C.; Steyaert, J.; Balzarini, J.; Daelemans, D.
  3. Rna Biology. 2011, Mar-Apr; 8(2): 316-324.
  1. 5.   Selective Modulation of DNA Polymerase Activity by Fixed-Conformation Nucleoside Analogues
  2. Eoff, R. L.; McGrath, C. E.; Maddukuri, L.; Salamanca-Pinzon, S. G.; Marquez, V. E.; Marnett, L. J.; Guengerich, F. P.; Egli, M.
  3. Angewandte Chemie-International Edition. 2010, Oct 4; 49(41): 7481-7485.
  1. 6.   Structure-Activity Analysis of Vinylogous Urea Inhibitors of Human Immunodeficiency Virus-Encoded Ribonuclease H
  2. Chung, S. M.; Wendeler, M.; Rausch, J. W.; Beilhartz, G.; Gotte, M.; O'Keefe, B. R.; Bermingham, A.; Beutler, J. A.; Liu, S. X.; Zhuang, X. W.; Le Grice, S. F. J.
  3. Antimicrobial Agents and Chemotherapy. 2010, Sep; 54(9): 3913-3921.
  1. 7.   Vif of Feline Immunodeficiency Virus from Domestic Cats Protects against APOBEC3 Restriction Factors from Many Felids
  2. Zielonka, J.; Marino, D.; Hofmann, H.; Yuhki, N.; Lochelt, M.; Munk, C.
  3. Journal of Virology. 2010, Jul; 84(14): 7312-7324.
  1. 8.   Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development
  2. Smith, J. L.; Bu, W.; Burdick, R. C.; Pathak, V. K.
  3. Trends in Pharmacological Sciences. 2009, Dec; 30(12): 638-646.
  1. 9.   Revisiting Plus-Strand DNA Synthesis in Retroviruses and Long Terminal Repeat Retrotransposons: Dynamics of Enzyme: Substrate Interactions
  2. Fabris, D.; Marino, J. P.; Le Grice, S. F. J.
  3. Viruses-Basel. 2009, Dec; 1(3): 657-677.
  1. 10.   Human T-Cell Lymphotropic Virus Type 1 Nucleocapsid Protein-Induced Structural Changes in Transactivation Response DNA Hairpin Measured by Single-Molecule Fluorescence Resonance Energy Transfer
  2. Darugar, Q.; Kim, H.; Gorelick, R. J.; Landes, C.
  3. Journal of Virology. 2008 82(24): 12164-12171.
  1. 11.   Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses
  2. Rulli, S. J.; Mirro, J.; Hill, S. A.; Lloyd, P.; Gorelick, R. J.; Coffin, J. M.; Derse, D.; Rein, A.
  3. Journal of Virology. 2008 82(13): 6566-6575.
  1. 12.   Retroviral Nucleocapsid Proteins Display Nonequivalent Levels of Nucleic Acid Chaperone Activity
  2. Stewart-Maynard, K. M.; Cruceanu, M.; Wang, F.; Vo, M. N.; Gorelick, R. J.; Williams, M. C.; Rouzina, I.; Musier-Forsyth, K.
  3. Journal of Virology. 2008 82(20): 10129-10142.
  1. 13.   High-resolution NMR analysis of the conformations of native and base analog substituted retroviral and LTR-retrotransposon PPT primers
  2. Yi-Brunozzi, H. Y.; Brinson, R. G.; Brabazon, D. I.; Lener, D.; Le Grice, S.; Marino, J. P.
  3. Chemistry & Biology. 2008 15(3): 254-262.
  1. 14.   Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3-Azido-3'-deoxythymidine resistance
  2. Delviks-Frankenberry, K. A.; Nikolenko, G. N.; Barr, R.; Pathak, V. K.
  3. Journal of Virology. 2007, Jul; 81(13): 6837-6845.
  1. 15.   Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques
  2. Luckay, A.; Sidhu, M. K.; Kjeken, R.; Megati, S.; Chong, S. Y.; Roopch, V.; Garcia-H, D.; Abdullah, R.; Braun, R.; Montefiori, D. C.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.; Mathiesen, I.; Israel, Z. R.; Eldridge, J. H.; Egan, M. A.
  3. Journal of Virology. 2007, May; 81(10): 5257-5269.
  1. 16.   Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT
  2. Nissley, D. V.; Radzio, J.; Ambrose, Z.; Sheen, C. W.; Hamamouch, N.; Moore, K. L.; Tachedjian, G.; Sluis-Cremer, N.
  3. Biochemical Journal. 2007, May; 404: 151-157.
  1. 17.   In vitro analysis of the effects of mutations in the G-tract of the human immunodeficiency virus type 1 polypurine tract on RNase H cleavage specificity
  2. Jones, F. D.; Hughes, S. H.
  3. Virology. 2007, Apr; 360(2): 341-349.
  1. 18.   Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites
  2. March, C.; Krajewski, K.; Lee, H. F.; Antony, S.; Johnson, A. A.; Amin, R.; Roller, P.; Kvaratskhelia, M.; Pommier, Y.
  3. Nucleic Acids Research. 2006, Oct; 34(18): 5157-5165.
  1. 19.   Combining mutations in HIV-1 reverse transcriptase with mutations in the HIV-1 polypurine tract affects RNase H cleavages involved in PPT utilization
  2. McWilliams, M. J.; Julias, J. G.; Sarafianos, S. G.; Alvord, W. G.; Arnold, E.; Hughes, S. H.
  3. Virology. 2006, May; 348(2): 378-388.
  1. 20.   Examining Ty3 polypurine tract structure and function by nucleoside analog interference
  2. Dash, C.; Marino, J. P.; Le Grice, S. F. J.
  3. Journal of Biological Chemistry. 2006, FEB 3; 281(5): 2773-2783.
  1. 21.   Chemical library screen for novel inhibitors of Kaposi's sarcoma-associated herpesvirus processive DNA synthesis
  2. Dorjsuren, D.; Burnette, A.; Gray, G. N.; Chen, X. L.; Zhu, W. M.; Roberts, P. E.; Currens, M. J.; Shoemaker, R. H.; Ricciardi, R. P.; Sei, S.
  3. Antiviral Research. 2006, JAN; 69(1): 9-23.
  1. 22.   Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: A new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains
  2. Himmel, D. M.; Das, K.; Clark, A. D.; Hughes, S. H.; Benjahad, A.; Oumouch, S.; Guillemont, J.; Coupa, S.; Poncelet, A.; Csoka, I.; Meyer, C.; Andries, K.; Nguyen, C. H.; Grierson, D. S.; Arnold, E.
  3. Journal of Medicinal Chemistry. 2005, DEC 1; 48(24): 7582-7591.
  1. 23.   A ribose sugar conformational switch in the LTR-retrotransposon Ty3 polypurine tract-containing RNA/DNA hybrid
  2. Yi-Brunozzi, H. Y.; Brabazon, D. M.; Lener, D.; Le Grice, S. F. J.; Marino, J. P.
  3. Journal of the American Chemical Society. 2005, NOV 30; 127(47): 16344-16345.
  1. 24.   Alternate polypurine tracts (PPTs) affect the Rous sarcoma virus RNase H cleavage specificity and reveal a preferential cleavage following a GA dinucleotide sequence at the PPT-U3 junction
  2. Chang, K. W.; Julias, J. G.; Alvord, W. G.; Oh, J.; Hughes, S. H.
  3. Journal of Virology. 2005, NOV; 79(21): 13694-13704.
  1. 25.   Crystallography and the design of anti-AIDS drugs: Conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors
  2. Das, K.; Lewi, P. J.; Hughes, S. H.; Arnold, E.
  3. Progress in Biophysics and Molecular Biology. 2005, JUN; 88(2): 209-231.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel